Purchases and Sales Made in Q2 2023 in Qualigen Therapeutics Inc Com (QLGNZZZZ)
This table provides information about the institutional ownership of Qualigen Therapeutics Inc Com (QLGNZZZZ) during Q2 2023. The information is specifically focused on institutions that hold shares of QUALIGEN THERAPEUTICS INC COM .
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Jul 24, 2023
Q2 2023
|
Meitav Dash Investments LTD
|
BUY
|
- |
27.3KNew |
N/A
|
27.3K
$0
|
|
Aug 14, 2023
Q2 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
2.63K+ 132.54% |
N/A
|
4.61K
$0
|
|
Aug 11, 2023
Q2 2023
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
385New |
N/A
|
385
$0
|
|
Aug 15, 2023
Q2 2023
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
7+ 24.14% |
N/A
|
36
$0
|
|
Aug 10, 2023
Q2 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
N/A
|
0
$0
|
|
Aug 11, 2023
Q2 2023
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-177- 0.79% |
N/A
|
22.2K
$0
|
|
Aug 11, 2023
Q2 2023
|
Ubs Group Ag
|
SELL
|
- |
-9.91K- 87.85% |
N/A
|
1.37K
$0
|